Describes the popular rationals for and social forces motivating amphetamine use in America and the often physically and psychologically damaging effects of the drugs.
Describes the popular rationals for and social forces motivating amphetamine use in America and the often physically and psychologically damaging effects of the drugs.
In Killer High, Peter Andreas tells the story of war from antiquity to the modern age through the lens of six psychoactive drugs: alcohol, tobacco, caffeine, opium, amphetamines, and cocaine. Armed conflict has become progressively more "drugged" with the global spread of these mind-altering substances. From ancient brews and battles to meth and modern warfare, drugs and war have grown up together and become addicted to each other. By looking back not just years and decades but centuries, Andreas reveals that the drugs-conflict nexus is actually an old story, and that powerful states have been its biggest beneficiaries.
A psychiatrist takes a critical look at this SSRI and newer medications that are among the most frequently prescribed drugs in America. Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro‐Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain—with few or no side effects. But is the reality quite different? At what price do we buy Prozac‐induced euphoria and a shiny new personality? Psychiatrist Peter Breggin, MD, and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works, and they take a hard look at the real story behind today’s most controversial drug: The fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval The difficulty Prozac’s manufacturer had in proving its effectiveness during these tests The information on side effects that the FDA failed to include in its final labeling requirements How Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine The dangers of possible Prozac addiction and abuse The seriousness and frequency of Prozac’s side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm The growing evidence that Prozac can cause violence and suicide The social and workplace implications of using the drug not to cure depression but to change personality and enhance performance Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it.
Tourism Destination Quality: Attributes and Dimensions critically compares dimensions of tourism destination quality established in the TDQ study with dimensions of product quality, service quality, place quality and destination service/product quality.
Chronic obstructive pulmonary disease (COPD), which encompasses both chronic bronchitis and emphysema, is one of the most common respiratory conditions of adults in the developed world. Asthma and COPD: Basic Mechanisms and Clinical Management provides a unique, authoritative comparison of asthma and COPD. Written and edited by the world's leading experts, it is a comprehensive review of the most recent understanding of the basic mechanisms of both conditions, specifically comparing their etiology, pathogenesis, and treatments. * Highlights distinguishing features between asthma and COPD * Reviews benefits and limitations of current therapies * Summarises key information in two-colour artwork * Extensively referenced to primary literature
Relied on for over 30 years by resident and practicing anesthesiologists and nurse anesthetists, this best-selling pocket reference is now in its Eighth Edition. In an easy-to-scan outline format, it provides current, comprehensive, concise, consistent, and clinically relevant guidelines for anesthesia, perioperative care, critical care, and pain management. The book has been written, reviewed, updated, and field-tested by the internationally recognized Department of Anesthesia, Critical Care and Pain Medicine at the Massachusetts General Hospital.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.